Pilot project will include the development of a Real-World Data and Analytics Platform
TUCSON, Ariz., October 27, 2020 — Arizona-based Critical Path Institute (C-Path) is pleased to announce it has been awarded a multi-year grant by the U.S. Food and Drug Administration (FDA) to advance standards and methodologies designed to generate real-world evidence (RWE) from real-world data (RWD) through a neonatal pilot project through the International Neonatal Consortium (INC).Continue reading
Partnership to Integrate HybridChart’s Rounding and Workflow Solution with PointClickCare’s EHR PlatformContinue reading
Access to early stage growth capital is an ongoing challenge to the growth of Arizona’s Bioindustry. To address this challenge, AZBio, in partnership with the Opportunity Through Entrepreneurship Foundation and with support from a US. Economic Development Agency (EDA) grant has developed AZAdvances. The Marketing Consultant will work with the AZBio Team to inspire the community and engage support.Continue reading
As part of its ongoing efforts to strengthen Arizona’s Bioscience and Medtech Entrepreneurial Ecosystem, AZBio encourages qualified post-doctorate applicants to apply to join our team as a Entrepreneurial Program Grants Administrator. This is a 1-year position.Continue reading
As part of its ongoing efforts to strengthen Arizona’s Bioscience and Medtech Entrepreneurial Ecosystem, AZBio encourages qualified applicants to apply to join our team as a Bioscience Entrepreneur-in-Residence (EIR).Continue reading
— Veklury Is First and Only FDA-Approved Treatment for COVID-19 in the United States —
— Veklury Shortened Time to Recovery By Five Days in Hospitalized COVID-19 Patients —
C-Path, NORD, FDA and more come together to showcase the importance of data sharing in rare disease drug development
TUCSON, Ariz. and WASHINGTON, D.C. October 21, 2020 — The Critical Path Institute (C-Path) and the National Organization for Rare Disorders (NORD®) hosted the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) 2020 Virtual Workshop on Monday, October 19. The platform, funded by a cooperative agreement through the U.S. Food and Drug Administration (FDA), serves as a centralized and standardized infrastructure to support data sharing and data analysis to aid in the understanding of rare diseases.Continue reading
Calviri, Inc., a biotech startup focused on ending deaths from cancer, announces that Skysong Innovations, the intellectual property management company for Arizona State University (“ASU”), granted Calviri an exclusive license to ASU’s Immunosignature patent portfolio. The portfolio consists of multiple granted and pending patents for the use and optimization of immunosignatures as an antibody-based diagnostic platform in the United States and the rest of the world.Continue reading
Bite Sized Science videos are a great resource for teachers, students, and anyone who wants to learn more about how science works.Continue reading